Professional oncology society
Appears in 1 story
Hosted the ESMO Congress 2026 where the substudy was presented
Nearly half of men with high-risk localized prostate cancer who have surgery see the cancer return within five years. New PROTEUS substudy data show that apalutamide plus hormone therapy for six months before and after surgery cuts that risk by 62% versus surgery alone.
Updated 2 hours ago
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
